[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience-Reference-Cited by-同舟云学术

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience

Published:2016-01-28 Issue:8 Volume:7 Page:9288-9295
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lapa Constantin¹,Lückerath Katharina¹,Rudelius Martina²,Schmid Jan-Stefan¹,Schoene Alexander³,Schirbel Andreas¹,Samnick Samuel¹,Pelzer Theo⁴,Buck Andreas K.¹,Kropf Saskia⁵,Wester Hans-Jürgen⁶,Herrmann Ken¹⁷

Affiliation:

1. Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

2. Institute for Pathology, University of Würzburg, Würzburg, Germany

3. Department of Internal Medicine, Caritas Hospital Bad Mergentheim, Bad Mergentheim, Germany

4. Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany

5. Scintomics GmbH, Fürstenfeldbruck, Germany

6. Pharmaceutical Radiochemistry, Technische Universität München, Munich, Germany

7. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The β2-adrenergic receptor associates with CXCR4 multimers in human cancer cells;Proceedings of the National Academy of Sciences;2024-03-28

2. Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor;Seminars in Nuclear Medicine;2024-01

3. CXCR4 Theranostics: A Potential Game Changer in Solid Tumors and Hematological Malignancies;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

4. CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-12

5. Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers;Radiation Research;2023-11-21